Apotex News
Most Popular Apotex Story
Sanofi, BMS collect their $444M in Plavix damages
Apotex has finally paid its Plavix dues. The generics maker has handed over $444 million to Sanofi ($SNY) and Bristol-Myers Squibb ($BMY), as repayment for its premature launch of generic Plavix back Read more...
Latest Headlines
- February 8, 2012
- October 19, 2011
- March 30, 2011
- October 20, 2010
- October 6, 2010
- August 17, 2010
- August 17, 2010
- August 10, 2010
- July 23, 2010
- July 15, 2010
- June 10, 2010
- November 3, 2009
- October 27, 2009
- September 21, 2009
- September 9, 2009
- July 29, 2009
- July 15, 2009
- May 21, 2009
- March 11, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
